Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ANPCY - ANGLE partners with BioView

ANPCY - ANGLE partners with BioView

Angle Plc Surrey ADR

2023-04-19 06:51:28 ET

  • ANGLE ( OTCQX:ANPCY ) signs an agreement with BioView to develop a liquid biopsy circulating tumor cell (or CTC) HER2 assay for breast cancer.
  • It will be utilising ANGLE's FDA cleared Parsortix PC1 Clinical System to harvest CTCs and BioView's automated microscopy systems and software to detect and assess the HER2 expression and/or gene amplification in CTCs.
  • The company has already successfully integrated BioView's technology in its R&D and clinical laboratories for assay development and pharma services.

For further details see:

ANGLE partners with BioView
Stock Information
Company Name: Angle Plc Surrey ADR
Stock Symbol: ANPCY
Market: OTC
Website: angleplc.com
Menu
ANPCY ANPCY Quote ANPCY Short ANPCY News ANPCY Articles ANPCY Message Board
Get ANPCY Alerts

News, Short Squeeze, Breakout and More Instantly...